HLS Therapeutics Company Top Insiders
| HLTRF Stock | USD 2.60 0.00 0.00% |
HLS Therapeutics employs about 92 people. The company is managed by 6 executives with a total tenure of roughly 215 years, averaging almost 35.0 years of service per executive, having 15.33 employees per reported executive. Examination of HLS Therapeutics' management performance can provide insight into the company performance.
| BA LLB Insider CoFounder Chairman |
| Sanjiv Sharma Insider Chief Officer |
HLS |
HLS Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.0276) % which means that it has lost $0.0276 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1442) %, meaning that it generated substantial loss on money invested by shareholders. HLS Therapeutics' management efficiency ratios could be used to measure how well HLS Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.HLS Therapeutics Workforce Comparison
HLS Therapeutics is rated # 2 in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 1,039. HLS Therapeutics holds roughly 92.0 in number of employees claiming about 9% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.35) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.19) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.19. HLS Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. HLS Therapeutics Price Series Summation is a cross summation of HLS Therapeutics price series and its benchmark/peer.
HLS Therapeutics Notable Stakeholders
A HLS Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as HLS Therapeutics often face trade-offs trying to please all of them. HLS Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting HLS Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| BA LLB | CoFounder Chairman | Profile | |
| Sanjiv Sharma | Chief Officer | Profile | |
| JD BA | HR Legal | Profile | |
| David Spence | Co Controller | Profile | |
| Gilbert Godin | CEO CoFounder | Profile | |
| Tim MBA | Chief Officer | Profile |
About HLS Therapeutics Management Performance
The success or failure of an entity such as HLS Therapeutics often depends on how effective the management is. HLS Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of HLS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the HLS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada. Hls Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 92 people.
HLS Therapeutics Workforce Analysis
Traditionally, organizations such as HLS Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare HLS Therapeutics within its industry.HLS Therapeutics Manpower Efficiency
Return on HLS Therapeutics Manpower
| Revenue Per Employee | 652.3K | |
| Revenue Per Executive | 10M | |
| Net Loss Per Employee | 142.6K | |
| Net Loss Per Executive | 2.2M |
Complementary Tools for HLS Pink Sheet analysis
When running HLS Therapeutics' price analysis, check to measure HLS Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLS Therapeutics is operating at the current time. Most of HLS Therapeutics' value examination focuses on studying past and present price action to predict the probability of HLS Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLS Therapeutics' price. Additionally, you may evaluate how the addition of HLS Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |